Bats are important reservoirs for various viruses, including paramyxoviruses like Morbillivirus, linked to significant health risks.Recent research has identified six distinct Morbillivirus strains in bats and non-human primates in Central and South America.Viral RNA concentrations found in infected animals suggest systemic infection without inducing severe illness.Vampire bats displayed neutralizing antibodies against a primary vampire bat Morbillivirus strain, pointing to non-fatal infections.Bat-associated Morbilliviruses use bat CD150 for cellular entry, maintaining conserved antigenic features despite sequence variations.Non-human primate Morbilliviruses utilize human receptors more efficiently than bat-associated viruses, potentially posing higher zoonotic risks.Morbilliviruses show host-shift events, suggesting the capacity to breach species barriers, with implications for zoonotic transmissions.Intensified surveillance targeting wildlife reservoirs is recommended to understand and mitigate the zoonotic threat of Morbilliviruses.The study highlights the need for proactive intervention strategies and vaccine development to combat potential emerging infectious diseases.Understanding the ecological and evolutionary dynamics of Morbilliviruses in bats is crucial for predicting and preventing future outbreaks.